David A. Siegel Otonomy, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.25 - $2.24 $9,500 - $85,120
38,000 Added 31.61%
158,200 $47,000
Q2 2022

Aug 15, 2022
SELL
$1.72 - $2.51 $78,604 - $114,706
-45,700 Reduced 27.55%
120,200 $250,000
Q1 2022

May 16, 2022
SELL
$1.72 - $2.47 $115,928 - $166,478
-67,400 Reduced 28.89%
165,900 $398,000
Q4 2021

Feb 14, 2022
SELL
$1.69 - $2.31 $131,417 - $179,630
-77,762 Reduced 25.0%
233,300 $485,000
Q3 2021

Nov 15, 2021
SELL
$1.22 - $2.2 $213,866 - $385,660
-175,300 Reduced 36.04%
311,062 $597,000
Q2 2021

Aug 16, 2021
BUY
$2.06 - $2.67 $39,758 - $51,531
19,300 Added 4.13%
486,362 $1.09 Million
Q1 2021

May 17, 2021
BUY
$2.49 - $6.23 $602,829 - $1.51 Million
242,100 Added 107.62%
467,062 $1.19 Million
Q4 2020

Feb 16, 2021
BUY
$3.48 - $6.47 $238,032 - $442,548
68,400 Added 43.69%
224,962 $1.46 Million
Q3 2020

Nov 16, 2020
BUY
$3.16 - $4.36 $420,159 - $579,714
132,962 Added 563.4%
156,562 $634,000
Q2 2020

Aug 14, 2020
SELL
$1.87 - $3.84 $187 - $384
-100 Reduced 0.42%
23,600 $85,000
Q1 2020

May 15, 2020
SELL
$1.58 - $4.06 $3,950 - $10,149
-2,500 Reduced 9.54%
23,700 $47,000
Q3 2019

Nov 14, 2019
SELL
$2.12 - $2.86 $15,264 - $20,592
-7,200 Reduced 21.56%
26,200 $63,000
Q2 2019

Aug 14, 2019
SELL
$2.35 - $3.09 $49,115 - $64,581
-20,900 Reduced 38.49%
33,400 $92,000
Q1 2019

May 15, 2019
SELL
$1.8 - $2.97 $8,460 - $13,959
-4,700 Reduced 7.97%
54,300 $143,000
Q4 2018

Feb 14, 2019
SELL
$1.51 - $2.93 $5,134 - $9,962
-3,400 Reduced 5.45%
59,000 $109,000
Q3 2018

Nov 14, 2018
SELL
$2.6 - $3.95 $34,320 - $52,140
-13,200 Reduced 17.46%
62,400 $172,000
Q2 2018

Aug 14, 2018
BUY
$3.7 - $4.75 $2,590 - $3,325
700 Added 0.93%
75,600 $291,000
Q1 2018

May 15, 2018
SELL
$4.05 - $6.1 $24,300 - $36,600
-6,000 Reduced 7.42%
74,900 $315,000
Q4 2017

Feb 14, 2018
SELL
$2.8 - $5.55 $157,640 - $312,465
-56,300 Reduced 41.03%
80,900 $449,000
Q3 2017

Nov 14, 2017
BUY
$3.2 - $20.8 $439,040 - $2.85 Million
137,200
137,200 $446,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email